A consensus paper published in 2025 provides pragmatic advice on the diagnosis and treatment of subsyndromal anxiety disorder (SSA). If it has been established that the patient has SSA, it is recommended that non-drug treatment measures be initiated first. If this does not lead to the desired success, drug therapy should be considered. Phytotherapeutic treatment with a standardized lavender oil extract has been shown to be effective and safe in studies of SSA.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Modern asthma therapies
New data on biologics and triple therapy
- From symptom to diagnosis
Abdominal Pain – Focal Nodular Hyperplasia
- Hepatology and Metabolism
The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend
- Peristomal skin health
Focus on preventive care options
- Case study
Discoid Lupus Erythematosus in a 38-Year-Old Woman
- Hand and Finger Injuries
Preventing Permanent Functional Limitations
- From an antidiabetic drug to a distinct class of cardiorenal therapies
The Incretin Revolution in Cardiology
- Prostate Cancer